Michael Kenneth Keng
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 15
- Multiple Myeloma Research and Treatments 3
- Chronic Myeloid Leukemia Treatments 3
- Hematopoietic Stem Cell Transplantation 3
- Oncology 13
- Neutropenia and Cancer Infections 7
- CAR-T cell therapy research 3
- Co-authors
- Mikkael Aaron Sekeres (7 shared papers)Firas El Chaer (7 shared papers)Amy Morris (9 shared papers)Karen Kuhn Ballen (2 shared papers)Daniel R. Reed (8 shared papers)Monja A. Dawson (1 shared paper)David G. Maloney (1 shared paper)Jan Storek (1 shared paper)
- Journals
- Current Hematologic Malignancy Reports (7 papers)Blood (6 papers)Journal of Oncology Practice (3 papers)Open Forum Infectious Diseases (2 papers)JCO Oncology Practice (2 papers)
- Partner nations
- United StatesPolandAustralia
In The Last Decade
Michael Kenneth Keng
41 papers receiving 567 citations
Peers
Comparison fields: 5 of 73
- Hematology 197
- Oncology 198
- Clinical Biochemistry 32
- Immunology 88
- Genetics 37
Countries citing papers authored by Michael Kenneth Keng
This map shows the geographic impact of Michael Kenneth Keng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kenneth Keng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kenneth Keng more than expected).
Fields of papers citing papers by Michael Kenneth Keng
This network shows the impact of papers produced by Michael Kenneth Keng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kenneth Keng. The network helps show where Michael Kenneth Keng may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kenneth Keng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 86 | |
| 2 | 2020 | 57 | |
| 3 | 2015 | 52 | |
| 4 | 2013 | 50 | |
| 5 | 2022 | 44 | |
| 6 | 2017 | 33 | |
| 7 | 2007 | 19 | |
| 8 | 2018 | 19 | |
| 9 | 2015 | 17 | |
| 10 | 2022 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2015 | 15 | |
| 13 | 2019 | 12 | |
| 14 | 2019 | 12 | |
| 15 | 2021 | 12 | |
| 16 | A drug's life: the pathway to drug approval. | 2013 | 11 |
| 17 | 2020 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2022 | 10 | |
| 20 | 2024 | 10 |
About Michael Kenneth Keng
Michael Kenneth Keng is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Pediatrics, Perinatology and Child Health, having authored 42 papers that have together received 584 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (12 papers), Neutropenia and Cancer Infections (7 papers), Histone Deacetylase Inhibitors Research (4 papers), CAR-T cell therapy research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (197 citations), Oncology (198 citations), Clinical Biochemistry (32 citations), Immunology (88 citations) and Genetics (37 citations). Michael Kenneth Keng has collaborated with scholars based in United States, Poland and Australia. Frequent co-authors include Mikkael Aaron Sekeres, Firas El Chaer, Amy Morris, Karen Kuhn Ballen, Daniel R. Reed, Monja A. Dawson, David G. Maloney, Jan Storek, Michael Boeckh and Barry E. Storer. Their work appears in journals such as Current Hematologic Malignancy Reports, Blood, Journal of Oncology Practice, Open Forum Infectious Diseases and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.